Day One Biopharmaceuticals, Inc.
DAWN
$7.46
$0.497.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 10.23% | 5.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.23% | 5.32% | |||
| Cost of Revenue | 30.55% | -3.29% | |||
| Gross Profit | 8.13% | 6.30% | |||
| SG&A Expenses | -1.22% | -1.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.10% | -24.02% | |||
| Operating Income | 14.84% | 37.14% | |||
| Income Before Tax | 15.76% | 39.24% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 15.76% | 45.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.76% | 45.22% | |||
| EBIT | 14.84% | 37.14% | |||
| EBITDA | 15.31% | 37.80% | |||
| EPS Basic | 16.06% | 45.36% | |||
| Normalized Basic EPS | 16.03% | 39.40% | |||
| EPS Diluted | 16.06% | 45.36% | |||
| Normalized Diluted EPS | 16.03% | 39.40% | |||
| Average Basic Shares Outstanding | 0.35% | 0.26% | |||
| Average Diluted Shares Outstanding | 0.35% | 0.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||